Skip to main content
Caplight Logo









MIVI Neuroscience

MIVI Neuroscience

Private
Eden Prairie, MinnesotaHealthcare & Life Scienceshttps://mivineuro.com/

Last Round

Debt

May 15, 2024

Total Funding Raised

$87.64M

Company Overview

MIVI Neuroscience is a healthcare company that develops and commercializes innovative clinical solutions and medical devices for neuro-interventional procedures to improve stroke treatment outcomes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurointerventional devicesaspiration catheterthrombectomy systemstroke interventionmechanical thrombectomyneurovascular devicesclot retrievalrevascularizationguide catheterischemic stroke treatmentneurointerventionendovascular therapystroke hardwareinterventional neuroradiologymedical device sales

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MIVI Neuroscience Comparables

Compare MIVI Neuroscience with similar companies based on industry and business-model similarity.

MIVI Neuroscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perfuze
90%
Q'Apel Medical
88%
RapidPulse
88%

MIVI Neuroscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMay 15, 2024
Series BJan 21, 2021
Series AMar 19, 2020
Series AMay 14, 2019
SeedSep 7, 2017
Seed
Mar 17, 2017

MIVI Neuroscience Investors

Notable investors and investment history

MIVI Neuroscience investors
InvestorRounds
Deerfield ManagementSeries B
Aphelion CapitalSeries B
Perceptive AdvisorsSeries B
Concord Health PartnersSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2024

    $9.25M debt round completed.

  • Mar 19, 2020

    $20M round completed.

MIVI Neuroscience Filings

Explore SEC and related filing metadata, where available.

MIVI Neuroscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MIVI Neuroscience's valuation, stock price, and market status.

Is MIVI Neuroscience a public or private company?

MIVI Neuroscience is a private company.

What is the current stock price of MIVI Neuroscience?

MIVI Neuroscience is a private company with no public stock price. No recent secondary market data is available.

How much is MIVI Neuroscience worth (valuation)?

Valuation information for MIVI Neuroscience is not publicly available.

Can I buy MIVI Neuroscience stock?

MIVI Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MIVI Neuroscience's last funding round?

MIVI Neuroscience's most recent funding round was Convertible Debt on May 24, 2024.

Who are the main investors in MIVI Neuroscience?

Key investors in MIVI Neuroscience include Deerfield Management, Perceptive Advisors, Concord Health Partners.

Will MIVI Neuroscience IPO soon?

No public IPO plans have been announced for MIVI Neuroscience.

How can I track MIVI Neuroscience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MIVI Neuroscience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEden Prairie, Minnesota
Year Founded2013
Last FundingMay 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?